http://dspace.bsuedu.ru/handle/123456789/46251 2026-04-05T21:30:59Z http://dspace.bsuedu.ru/handle/123456789/46625 Title: Ischemia/reperfusion effect on pancreatic volumetrical blood flow velocity Authors: Kolmykov, D. I.; Alehin, S. A. Abstract: We investigate blood flow velocity at ischemia/reperfusion early stages. Transient hyperemia absence after ischemia/reperfusion cased by pancreatic edema development at early stages confirmed by Wet/Dry ratio elevation and morphological changes was determined 2015-01-01T00:00:00Z http://dspace.bsuedu.ru/handle/123456789/46624 Title: Study of the microcirculation level in bone with osteoporosis and osteoporotic fractures during therapy with recombinant erythropoietin, rosuvastatin and their combinations Authors: Rajkumar, D. S. R.; Gudyrev, O. S.; Faitelson, A. V.; Pokrovskii, M. V. Abstract: The experiment was carried out in female white Wistar rats. The effects of recombinant erythropoietin, rosuvastatin and their combination were investigated based on the blood supply to the bone after a modelled experimental osteoporosis. It was found that the studied drugs prevent decrease of bone microcirculation in cases of osteoporosis and in callus tissue in experimental osteoporotic fractures, positively influencing the course of reparative regeneration of bone tissue 2015-01-01T00:00:00Z http://dspace.bsuedu.ru/handle/123456789/46547 Title: Concomitant use of statins and s-(2-boron-ethyl)-l-cysteine arginase inhibitor to correct endotoxin-induced endothelial dysfunction Authors: Denisiuk, T. A.; Demchenko, S. A.; Saroyan, K. V. Abstract: The concomitant use of non-selective S-(2-boron-ethyl)-L-cysteine (BEC) arginase inhibitor with simvastatin, atorvastatin, rosuvastatin and nanoparticulated rosuvastatin on the background of endotoxin-induced disorder modeling by Staphylococcus aureus (strain 13407) injection under the skin – 60 billions of microbial bodies – exhibits an endothelium- and cardioprotective action which is evident as endothelial dysfunction factor (EDF) increase prevention, adrenoreactivity, maintenance of myocardial reserve, and normalization of biochemical markers (total NO, expression of eNOS, C-reactive protein, IL-6, tumor necrosis factor) 2015-01-01T00:00:00Z http://dspace.bsuedu.ru/handle/123456789/46546 Title: Human recombinant erythropoietin gradient dosage influence on ischemic and reperfusion liver injury Authors: Alehin, S. A.; Kolmykov, D. I.; Pokrovskii, M. V. Abstract: We investigate influence of human recombinant erythropoietin different dosage on blood flow velocity and morphological changes in liver during ischemic and reperfusion injury. It was proved what optimal preconditioning dosage is 50 IU/kg 2015-01-01T00:00:00Z